What is the difference between a stroke and a transient ischemic attack?

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

1. 1

   Transient ischemic attack (Wikipedia)

   WikipediaPublished Oct 7, 2026Checked Oct 17, 2026

   “A transient ischemic attack (TIA), commonly known as mini-stroke, is a temporary, or transient, stroke with noticeable symptoms that end within 24 hours. A TIA causes the same symptoms of stroke, such as weakness or numbness on one side of the body, sudden dimming or loss of vision, difficulty speaking or understanding language, and slurred speech. All forms of stroke, including a TIA, result from a disruption in blood flow to the central nervous system. A TIA is caused by a temporary disruption in blood flow to the brain, or cerebral blood flow (CBF). The primary difference between a major stroke and a TIA's minor stroke is how much tissue death (infarction) can be detected afterwards through medical imaging. While a TIA must by definition be associated with symptoms, strokes can also be asymptomatic or silent. In a silent stroke, also known as a silent cerebral infarct (SCI), there is permanent infarction detectable on imaging, but there are no immediately observable symptoms. The same person can have major strokes, minor strokes, and silent strokes, in any order.”

2. 2

   Quantitative MRI Susceptibility: Mapping of Transient Ischemic Attack-A Preliminary Study.

   Journal of imaging (Gruber et al.)Published Aug 17, 2026Checked Oct 17, 2026

   “A transient ischemic attack (TIA) is a transient episode of neurological dysfunction without evidence of acute infarct demarcation on neuroimaging. The radiographic features of TIAs are uncertain, as since there is currently no perfect imaging method with which to differentiate a stroke from a TIA. We aimed to evaluate whether regional abnormalities are associated with TIA by identifying tissue with increased susceptibility (χ) values using quantitative susceptibility mapping (QSM). A total of 39 adults with clinical TIA symptoms (66 ± 12 years) and 39 age- and sex matched controls (65 ± 12 years) underwent MRI. Based on the QSM-maps, local susceptibility changes were tested for statistically significant differences between patients with TIA and healthy controls. The susceptibility maps of TIA patients showed that magnetic susceptibility differed from that of healthy volunteers, with the strongest effects observable in the right lingual gyrus (p p < 0.01). TIA is often difficult to diagnose at the time of presentation in the emergency department, and QSM could show an association between regional QSM abnormalities and TIA.”

3. 3

   Diagnostic value of 3D arterial spin labeling plus diffusion-weighted imaging for transient ischemic attack and short-term stroke prognosis: A retrospective cohort study.

   Medicine (Fu et al.)Published Mar 1, 2026Checked Oct 17, 2026

   “Imaging included DWI (b = 0,1000 seconds/mm2), 3D-ASL with dual post-labeling delays, and MR angiography. Clinical data and ABCD2 scores were collected, with 90-day stroke follow-up. Diagnostic performance and prognostic factors were analyzed using ROC curves and Cox regression. DWI detected acute lesions in 37 patients (34.9%), while 3D-ASL revealed cerebral hypoperfusion in 64 (60.4%), including 35 DWI-negative cases. Combined imaging improved 90-day stroke prediction (AUC 0.854; sensitivity 93.8%, specificity 71.1%) versus DWI alone (AUC 0.761) or 3D-ASL alone (AUC 0.790) (P 15 mL (HR 2.87, 95% CI: 1.06-7.78), and ABCD2 score ≥4 (HR 3.01, 95% CI: 1.09-8.31) as independent predictors. Symptom duration ≥1 hour correlated with higher DWI positivity (47.7% vs 25.8%, P = .012) and larger hypoperfusion volumes (16.8 vs 9.2 mL, P = .004). Combining 3D-ASL with DWI significantly improves cerebrovascular pathology detection and 90-day stroke risk prediction beyond clinical scoring, identifying high-risk TIA patients for intensified secondary prevention.”

4. 4

   Short-term risk of recurrent stroke in symptomatic carotid near-occlusion: pooled analysis of three cohort studies.

   European stroke journal (García-Pastor & Johansson)Published Aug 1, 2026Checked Oct 17, 2026

   “Per-cohort rates differed markedly (TACNOS 23.9%, UCC 22.3%, CAOS 8.1%; I2 = 77%, P = .012). By visual appearance (n = 333), 90-day stroke risk did not differ by collapse status (adjHR 1.5; 95% CI, 0.8-2.9). By measurement (n = 219), full collapse was associated with higher stroke risk (adjHR 2.0; 95% CI, 1.0-3.9). For both definitions, full collapse strongly predicted 0-2 day recurrence (adjHR 4.0; 95% CI, 1.5-10.5 and adjHR 4.8; 95% CI, 1.8-12.8). Full collapse combined with TIA identified a subgroup with 90-day stroke risk of 37.8% (by appearance) and 50.4% (by measurement).DiscussionFindings should be interpreted in the context of substantial between-study heterogeneity and informative censoring; sensitivity analyses confirmed the robustness of the estimates.ConclusionsCarotid near-occlusion with full collapse carries a markedly elevated risk of stroke recurrence within 48 h, supporting dedicated trials of urgent revascularisation strategies. In exploratory analysis, presentation with TIA appeared to identify a particularly high-risk subgroup, a hypothesis-generating observation that requires independent validation.”

5. 5

   Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials.

   Stroke and vascular neurology (Yang et al.)Published Jun 29, 2026Checked Oct 17, 2026

   “Random effects models generated risk ratio (RR) with 95% CIs for outcomes including stroke, composite vascular events, ischaemic stroke, major bleeding, haemorrhagic stroke and all-cause mortality.ResultsPooled data from five trials (n=27 559) demonstrated that DAPT versus monotherapy lowered the risk of stroke recurrence (RR, 0.77; 95% CI 0.70 to 0.83), composite vascular events (RR, 0.75; 95% CI 0.68 to 0.83) and ischaemic stroke (RR, 0.74; 95% CI 0.68 to 0.81). However, DAPT increased the risk of major bleeding (RR, 2.19; 95% CI 1.38 to 3.49) and haemorrhagic stroke (RR, 2.08; 95% CI 1.13 to 3.82), with no significant increase in the risk of all-cause mortality (RR, 1.28; 95% CI 0.95 to 1.71).ConclusionsFor acute mild stroke (NIHSS ≤5) or patients with TIA within 72 hours of ictus, early DAPT initiation demonstrates net clinical benefit through reducing ischaemic events, despite an increase in bleeding complications, without affecting mortality.”